Hoersholm, 2012-10-22 15:13 CEST (GLOBE NEWSWIRE) --
Company announcement no. 50/2012
Chr. Hansen Holding A/S change the date for release of its Interim report (Q3 2012/13) to
3 July 2013 (previously planned at 4 July 2013):
Financial calendar 2012/13
2013
16 January Interim Report (Q1 2012/2013)
11 April Interim Report (Q2 2012/2013)
3 July Interim Report (Q3 2012/2013)
23 October Annual Report 2012/2013
26 November Annual General Meeting
Please note that subjects and proposals that shareholders wish to be addressed at the Annual General Meeting will be added to the agenda if such a request is submitted to the Board of Directors no later than on Monday 14 October at 16.00 CET.
For further information, please contact:
Anders Mohr Christensen, Senior Director, Investor Relations
Tel: +45 4574 7618
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products are centered around cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2010/11 financial year was EUR 636 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,400 dedicated employees in over 30 countries. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen. For further information, please visit www.chr-hansen.com.
